Patent · US Active

Anti-EGFR conformational single domain antibodies and uses thereof

US10287360B2 · kind B2 · utility

0Cited by
0References
13Claims
0Family size

Assignees

Inventors

Key dates

Filing dateMay 22, 2015
Grant dateMay 14, 2019
Priority date
Expiry dateMay 22, 2035

Classification

  • Technology area (CPC G)Physics
  • CPC primaryG01N2333/71
  • WIPO fieldMeasurement
  • WIPO sectorInstruments

Abstract

The present invention relates to anti-Epidermal Growth Factor Receptor (EGFR) conformational single domain antibodies and uses thereof in particular in the therapeutic and diagnostic field.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.